Pathological complete response after neoadjuvant therapy for rectal cancer and the role of adjuvant therapy.

Item

http://www.wikidata.org/entity/Q38079162

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pathological complete response ...... the role of adjuvant therapy.

@en

type

Item

label

Pathological complete response ...... the role of adjuvant therapy.

@en

prefLabel

Pathological complete response ...... the role of adjuvant therapy.

@en

P1476

Pathological complete response ...... the role of adjuvant therapy.

@en

P2093

Al B Benson

http://www.w3.org/2001/XMLSchema#string

Valerie M Nelson

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2012

Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients

Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial.

Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis.

Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Chemotherapy with preoperative radiotherapy in rectal cancer.

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.

Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial.

P2888

s11912-013-0297-5

P304

152-161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-013-0297-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1037825931

http://www.w3.org/2001/XMLSchema#string

P698

23381584

http://www.w3.org/2001/XMLSchema#string